My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.890 +0.270 (+3.13%)
Official Closing Price Updated: 4:15 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,499,223
Open 8.660
Bid (Size) 8.900 (1)
Ask (Size) 8.950 (5)
Prev. Close 8.620
Today's Range 8.530 - 9.040
52wk Range 5.010 - 13.34
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion. 
Via Benzinga
Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity
Shah Capital currently owns 11.8 million shares or 7.2% of Novavax. 
Via Stocktwits

Performance

YTD
+3.7%
+3.7%
1 Month
+10.0%
+10.0%
3 Month
+29.2%
+29.2%
6 Month
+39.1%
+39.1%
1 Year
-29.6%
-29.6%

More News

Read More
ConnectM Exits Nasdaq for OTCQB Venture Market: A Deep Dive into Delisting, Challenges, and a Path Forward
Via MarketMinute
Topics Artificial Intelligence Economy
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda
Via Stocktwits
India's Tech Ascent: A 'Mission Mode' for Global Leadership in Semiconductors, Quantum, AI, and Biomanufacturing
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Novavax Amends Deal With Sanofi, Broadens Partnership
Via Stocktwits
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
Via Benzinga
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'
Via Benzinga
Topics Government
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
Via Investor's Business Daily
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Via Benzinga
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
Via Investor's Business Daily
Topics Government
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
Via Benzinga
FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects
Via Benzinga
Topics Death
Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?
Via Investor's Business Daily
Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speed
Via Benzinga
Topics Government
Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements
Via Benzinga
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster'
Via Benzinga
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works
Via Benzinga
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens
Via Benzinga
Elizabeth Warren Slams Trump's CDC Purge: Calls Out RFK Jr's Statements On Measles Vaccines — 'These Fools Can't Be Trusted With Your Health'
Via Benzinga
Topics Government
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
Via Benzinga
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.
Via Investor's Business Daily
Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups
Via Stocktwits
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'
Via Benzinga
Topics Government
Novavax Stock Suffers Sharpest Drop In Months After $225M Debt Deal; Retail Still Leans Bullish
Via Stocktwits

Frequently Asked Questions

Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 8.890
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 10/14/25 04:15 PM ET
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 662.16M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 662M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.